DECOR Information for Project: International Patient Summary (IPS) (hl7ips-) |
HTML | Name | Effective Date | Version Label | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Templates with direct association to a transaction | ||||||||||||
html | ![]() |
2020‑05‑08 12:30:59 | ||||||||||
The International Patient Summary is a "Minimal and non-exhaustive Patient Summary, specialty-agnostic, condition-independent, but readily usable by all clinicians for the unsched... | ||||||||||||
|
||||||||||||
CDA Document Level Template | ||||||||||||
![]() |
Multiple (2) | |||||||||||
The International Patient Summary is a "Minimal and non-exhaustive Patient Summary, specialty-agnostic, condition-independent, but readily usable by all clinicians for the unsched... | ||||||||||||
html | ![]() |
2020‑05‑08 12:30:59 | ||||||||||
html | ![]() |
2017‑04‑11 | STU1 | |||||||||
CDA Header Level Template | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA AssignedEntity (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
vpsee-
|
2017‑09‑28 13:02:41 | ||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Organization (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Person (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
vpsee-
|
2017‑09‑28 13:04:15 | ||||||||||
html | ![]() |
2017‑04‑11 | STU1 | |||||||||
A CDA document shall have at least one author. Authors could be either human (ClinicalDocument/author/assignedAuthor/assignedPerson) either devices (ClinicalDocument/author/assignedA... | ||||||||||||
html | ![]() |
2017‑04‑11 | STU1 | |||||||||
The custodian element represents the organization that is in charge of maintaining and is entrusted with the care of the document. This information is required ... | ||||||||||||
html | ![]() |
2017‑04‑12 | STU1 | |||||||||
The documentationOf relationship in an International Patient Summary contains the representation of providers who are wholly or partially responsible for the safety and well-being of a subject of care... | ||||||||||||
html | ![]() |
2017‑04‑11 | STU1 | |||||||||
The legalAuthenticator identifies the single person legally responsible for the document and must be present if the document has been legally authenticated. A clinical document that ... | ||||||||||||
html | ![]() |
2017‑04‑11 | STU1 | |||||||||
This is a reusable template providing essential information for describing / identifying an organization. | ||||||||||||
html | ![]() |
2017‑04‑12 | STU1 | |||||||||
Person name | ||||||||||||
html | ![]() |
2017‑04‑11 | STU1 | |||||||||
The recordTarget records the administrative and demographic data of the patient whose health information is described by the clinical document; each recordTarget must contain at least one patientRole ... | ||||||||||||
html | ![]() |
2017‑04‑12 | STU1 | |||||||||
An IPS may have three types of parent document: A superseded version that the present instance of the document wholly repla... | ||||||||||||
html | ![]() |
2017‑04‑12 | STU1 | |||||||||
The IPS may record several kinds of patient contacts, including parents, relatives, caregivers, and others related in some way to the patient. A patient contact may be an individual or an organization... | ||||||||||||
html | ![]() ref
vpsee-
|
2017‑04‑20 10:10:48 | ||||||||||
CDA Section Level Template | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2015‑10‑05 15:57:07 | 2014 | |||||||||
The vital signs section contains coded measurement results of a patient’s vital signs. | ||||||||||||
![]() |
Multiple (2) | |||||||||||
The advance directive section shall contain a narrative description of patient's advance directive. The optional author and informant elements are used when ne... | ||||||||||||
html | ![]() |
2020‑05‑08 16:38:49 | ||||||||||
html | ![]() |
2017‑04‑13 | STU1 | |||||||||
html | ![]() |
2016‑11‑11 | STU1 | |||||||||
This section documents the relevant allergies or intolerances (conditions) for that patient, describing the kind of reaction (e.g. rash, anaphylaxis,..); preferably the agents that c... | ||||||||||||
![]() |
Multiple (2) | |||||||||||
The functional status section shall contain a narrative description of capability of the patient to perform acts of daily living, including possible needs of the patient to be continuously assessed by... | ||||||||||||
html | ![]() |
2020‑05‑08 19:17:37 | ||||||||||
html | ![]() |
2017‑04‑13 | STU1 | |||||||||
html | ![]() |
2017‑04‑12 | STU1 | |||||||||
The History of Past Illness section contains a narrative description and coded entries of the conditions the patient suffered in the past. The optional author and informant elements are used when nec... | ||||||||||||
![]() |
Multiple (3) | |||||||||||
The history of pregnancy section shall contain information about whether the patient is currently pregnant (optional with the Expected Delivery Date) or not. I... | ||||||||||||
html | ![]() |
2020‑05‑07 18:46:08 | ||||||||||
html | ![]() |
2018‑09‑06 09:46:57 | STU1 | |||||||||
html | ![]() |
2017‑04‑13 | STU1 | |||||||||
html | ![]() |
2017‑03‑27 | STU1 | |||||||||
The History of Procedures Section contains a description of the patient past procedures that are pertinent to the scope of this document. Procedu... | ||||||||||||
html | ![]() |
2017‑04‑05 | STU1 | |||||||||
The Immunizations Section defines a patient's current immunization status and pertinent immunization history. The primary use case for the Immunization Section is to enable communication of a patient... | ||||||||||||
html | ![]() |
2017‑04‑11 | STU1 | |||||||||
The medical devices section contains narrative text and coded entries describing the patient history of medical device use. Medical devices include, but are not limited to, implanted devices and devi... | ||||||||||||
html | ![]() |
2016‑11‑11 | STU1 | |||||||||
The medication summary section contains a description of the patient's medications relevant for the scope of the patient summary. The actual content could depen... | ||||||||||||
![]() |
Multiple (2) | |||||||||||
The care plan section contains a narrative description of the expectations for care including proposals, goals, and order requests for monitoring, tracking, or improving the conditio... | ||||||||||||
html | ![]() |
2020‑05‑08 18:28:38 | ||||||||||
html | ![]() |
2017‑04‑13 | STU1 | |||||||||
html | ![]() |
2017‑02‑15 | STU1 | |||||||||
The IPS problem section lists and describes clinical problems or conditions currently being monitored for the patient. This section can record different kinds of problems as, but not limited to, chr... | ||||||||||||
html | ![]() |
2017‑04‑30 | STU1 | |||||||||
This section assembles relevant observation results collected on the patient or produced on in-vitro biologic specimens collected from the patient. Some of these results may be laboratory results, oth... | ||||||||||||
![]() |
Multiple (3) | |||||||||||
The social history section contains a description of the person’s Health related “lifestyle factors" or "lifestyle observations" (e.g. smoke habits; alcohol consumption; diets, risky habits.) The opti... | ||||||||||||
html | ![]() |
2020‑05‑10 18:52:32 | ||||||||||
html | ![]() |
2020‑05‑10 18:52:19 | STU1 | |||||||||
html | ![]() |
2017‑04‑13 | STU1 | |||||||||
html | ![]() |
2017‑07‑12 | STU1 | |||||||||
Template CDA Section to carry the translations of a Parent Section | ||||||||||||
html | ![]() |
2020‑05‑08 19:22:15 | ||||||||||
The vital signs section contains coded measurement results of a patient’s vital signs. | ||||||||||||
CDA Entry Level Template | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Act (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Author (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Clinical Statement (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Device (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Encounter (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA ExternalAct (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA ExternalDocument (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA ExternalObservation (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA ExternalProcedure (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Informant Body (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA LabeledDrug (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA ManufacturedProduct (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Material (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Observation (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA ObservationMedia (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Organizer (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Participant (Body) (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Performer (Body) (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
vpsee-
|
2017‑05‑04 18:46:37 | ||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA PlayingEntity (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Precondition (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Procedure (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Reference (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA RegionOfInterest (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA RelatedEntity (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Specimen (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Subject Body (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA SubstanceAdministration (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Supply (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2016‑09‑29 09:22:49 | 2014 | |||||||||
A vital signs observation is a simple observation that uses a specific vocabulary, and inherits constraints from CCD. | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
A vital signs organizer collects vital signs observations. | ||||||||||||
html | ![]() |
2020‑05‑08 16:21:54 | ||||||||||
This clinical statement represents Advance Directive Observation findings (e.g., “resuscitation status is Full Code”) rather than orders. It should not be considered a legal document or a substitute f... | ||||||||||||
html | ![]() |
2020‑05‑08 16:11:48 | ||||||||||
This clinical statement groups a set of advance directive observations. | ||||||||||||
html | ![]() |
2016‑11‑11 | STU1 | |||||||||
This template reflects an ongoing concern on behalf of the person that placed the allergy on a patient’s allergy list. A concern may refer to one or more allergies or intolerances. There are different... | ||||||||||||
html | ![]() |
2018‑02‑07 12:00:44 | STU1 | |||||||||
This observation represents the certainty associated with a propensity, or potential risk, of a reaction to the identified substance. | ||||||||||||
html | ![]() |
2016‑11‑10 | STU1 | |||||||||
This template reflects a discrete observation about a patient's allergy or intolerance. Because it is a discrete observation, it will have a statusCode of "completed". The eff... | ||||||||||||
html | ![]() |
2017‑05‑24 | STU1 | |||||||||
This subordinated observation used by the allergy observation records information about the current status of an allergy or intolerance, for example, whether it is active, in remission, resolved, et c... | ||||||||||||
html | ![]() |
2017‑03‑02 | STU1 | |||||||||
This template represents the Author Participation (including the author timestamp). CDA R2 requires that Author and Author timestamp be asserted in the document header. From there, authorship propagat... | ||||||||||||
html | ![]() |
2017‑04‑12 | STU1 | |||||||||
This template provides basic information about a device | ||||||||||||
html | ![]() |
2017‑03‑29 | STU1 | |||||||||
This observation represents the verification status to support the clinical status of the condition. | ||||||||||||
html | ![]() |
2017‑04‑05 | STU1 | |||||||||
Comments are free text data that cannot otherwise be recorded using data elements already defined by this specification. They are not to be used to record information that can be recorded elsewhere. F... | ||||||||||||
html | ![]() |
2017‑03‑27 | STU1 | |||||||||
This observation represents the gravity of the potential risk for future life-threatening adverse reactions when exposed to a substance known to cause an adverse reaction in that individual. When the ... | ||||||||||||
html | ![]() |
2017‑04‑07 10:00:14 | 0 | |||||||||
This entry allows for a comment to be supplied with each entry. For CDA this structure is usually included in the target act using the <entryRelationship> element defined in the CDA Schema, but can al... | ||||||||||||
html | ![]() |
2017‑05‑02 18:36:45 | ||||||||||
(CCD) Any problem or allergy observation may reference a problem status observation. This structure is included in the target observation using the <entryRelationship> element define... | ||||||||||||
html | ![]() |
2017‑03‑08 | STU1 | |||||||||
An Immunization entry describes immunization substance administrations that have actually occurred. | ||||||||||||
html | ![]() |
2017‑03‑08 | STU1 | |||||||||
The Immunization Medication Information represents product information about the immunization substance. The vaccine manufacturer and vaccine lot number are typically recorded in the medical record an... | ||||||||||||
html | ![]() |
2017‑05‑02 | STU1 | |||||||||
This template is used to reference (point to) information contained in other entries within the same document. | ||||||||||||
html | ![]() |
2017‑03‑21 | STU1 | |||||||||
This template constrains the results of a clinical laboratory observation. The result observation includes a statusCode to allow recording the status of an observation. “Pending” results (e.g., a test... | ||||||||||||
html | ![]() |
2016‑11‑10 | STU1 | |||||||||
This entry provides details about the medicinal product. Due to the current absence of global product identifiers the product is described through a set of identifi... | ||||||||||||
html | ![]() |
2017‑04‑11 | STU1 | |||||||||
The medical devices entry content module describes the kind of device that is, or has been used by the patient | ||||||||||||
html | ![]() |
2016‑11‑10 | STU1 | |||||||||
This entry describes the consumable subject of the medication statement. All the information about the medication is provided in the included IPS Manufactured Material template. | ||||||||||||
html | ![]() |
2016‑11‑11 | STU1 | |||||||||
An IPS Medication entry describes a medication statement, that is a substance administration that has actually occurred (e.g., pills ingested or injections given) or are intended to ... | ||||||||||||
html | ![]() |
2017‑04‑06 | STU1 | |||||||||
Template CDA ObservationMedia for IPS (prototype, directly derived from POCD_RM000040 MIF) This element is intended to carry a small multimedia content, like an image or a graph to be rendered in the ... | ||||||||||||
html | ![]() |
2017‑03‑21 | STU1 | |||||||||
This template constrains the results of an anatomic pathology observation. The result observation includes a statusCode to allow recording the status of an observation. “Pending” results (e.g., a tes... | ||||||||||||
html | ![]() |
2020‑05‑08 18:08:52 | ||||||||||
This template represents a Planned Act. It may be a wrapper for intervention-type activities considered to be parts of the same intervention; or it could be used to describe planned acts not rep... | ||||||||||||
html | ![]() |
2020‑05‑08 18:18:38 | ||||||||||
An Encounter is an interaction between a patient and care provider(s) for the purpose of providing healthcare-related service(s). Healthcare services include health assessment. Examp... | ||||||||||||
html | ![]() |
2020‑05‑08 17:29:18 | ||||||||||
A Planned Immunization entry describes the intent of administrating immunization substance. | ||||||||||||
html | ![]() |
2020‑05‑08 18:34:42 | ||||||||||
The observation request entry is used to record goals, plans or intention for an observation to be performed (e.g., assessment, laboratory test, imaging study, et cetera). | ||||||||||||
html | ![]() |
2020‑05‑08 17:38:48 | ||||||||||
The procedure entry is used to record procedures which are planned for in the future. | ||||||||||||
html | ![]() |
2017‑04‑13 | STU1 | |||||||||
This observation records the Pregnancy Expected Delivery Date for pregnant patients, expressed as a time stamp. The code reflects the method (operationalisation) of how the date was ... | ||||||||||||
html | ![]() |
2020‑05‑07 18:36:37 | ||||||||||
A pregnancy observation is a Simple Observation that uses a specific vocabulary to record observations about a patient's current or historical pregnancies. | ||||||||||||
html | ![]() |
2017‑04‑13 | STU1 | |||||||||
A pregnancy outcome observation records a summary over all pregnancies. | ||||||||||||
![]() |
Multiple (2) | |||||||||||
A pregnancy status observation records whether the patient is currently pregnant or not. If pregnant, an Expected Delivery Date may be specified as an subordinate observation. | ||||||||||||
html | ![]() |
2020‑05‑07 19:22:01 | ||||||||||
html | ![]() |
2017‑04‑13 | STU1 | |||||||||
html | ![]() |
2017‑02‑15 | STU1 | |||||||||
This template reflects an ongoing concern on behalf of the provider that placed the concern on a patient’s problem list. The purpose of the concern act is that of supporting the tra... | ||||||||||||
html | ![]() |
2017‑02‑15 | STU1 | |||||||||
This template reflects a discrete observation about a patient's problem. Because it is a discrete observation, it will have a statusCode of "completed". The effectiveTime, also refer... | ||||||||||||
html | ![]() |
2017‑03‑29 | STU1 | |||||||||
This subordinated observation used by the problem observation records information about the current status of a condition, for example, whether it is active, in remission, resolved, et cetera. | ||||||||||||
html | ![]() |
2017‑03‑27 | STU1 | |||||||||
The procedure entry is used to record procedures that have occurred, or which are planned for in the future. | ||||||||||||
html | ![]() |
2017‑03‑21 | STU1 | |||||||||
This template represents an observation produced as one of the results of a radiology or other imaging study performed on a patient. In most cases, in the context of a patient summary this observatio... | ||||||||||||
html | ![]() |
2016‑11‑15 | STU1 | |||||||||
This clinical statement represents the response to an undesired symptom, finding, etc. due to administered or exposed substance. This reaction may be an undesired symptom, finding, etc. or it could be... | ||||||||||||
html | ![]() |
2017‑03‑02 | STU1 | |||||||||
This generic template is the basic set of constraints, which apply to any kind of observation grouped in a Result Organizer. The IPS Result Observation template is generic. It is further specialized b... | ||||||||||||
html | ![]() |
2017‑03‑02 | STU1 | |||||||||
This template provides a mechanism for grouping result observations. It contains information applicable to all of the contained result observations. The Result Organizer code categorizes the contained... | ||||||||||||
html | ![]() |
2017‑04‑07 | STU1 | |||||||||
This clinical statement represents the subjective assessment of the severity of the condition as evaluated by the clinician. The Severity Observation can be associated with a Reactio... | ||||||||||||
html | ![]() |
2017‑06‑29 | STU1 | |||||||||
This template is a specialization of the Social History Observation that may be used to represent alcohol consumption habits. | ||||||||||||
html | ![]() |
2020‑05‑10 15:16:16 | ||||||||||
This template represents a patient's occupations, lifestyle, and environmental health risk factors. Demographic data (e.g., marital status, race, ethnicity, religious affiliation) are captured in the ... | ||||||||||||
html | ![]() |
2017‑06‑20 | STU1 | |||||||||
This template is a specialization of the Social History Observation that may be used to represent smoking or tobacco habits. | ||||||||||||
html | ![]() |
2017‑04‑14 | STU1 | |||||||||
Specimen Collection is used when a set of laboratory or pathology observations produced on one or more specimens need to be associated with the minimal characteristics of the specimen(s): specimen so... | ||||||||||||
html | ![]() |
2017‑06‑15 | STU1 | |||||||||
This entry is used by a main substanceAdministration act to provide dosage information as the frequency of intakes or the amount of the medication given. | ||||||||||||
html | ![]() |
2020‑05‑08 19:05:11 | ||||||||||
Survey observations are used to record responses to assessment instruments. They are simple observations conforming to the CCD Result template. The vocabulary and data type constrain... | ||||||||||||
html | ![]() |
2020‑05‑08 19:02:26 | ||||||||||
A survey panel collects related survey observations. | ||||||||||||
html | ![]() |
2020‑05‑08 19:31:32 | ||||||||||
A vital signs observation is a simple observation that uses a specific vocabulary, and inherits constraints from CCD. | ||||||||||||
html | ![]() |
2020‑05‑08 19:27:39 | ||||||||||
A vital signs organizer collects vital signs observations. | ||||||||||||
![]() |
Multiple (2) | |||||||||||
This element encodes the start and stop time of the medication regimen. This is an interval of time (xsi:type='IVL_TS'), and must be specified as shown. This is an additional constraint placed upon C... | ||||||||||||
html | ![]() ref
pharmcda-
|
2017‑05‑02 | ||||||||||
html | ![]() ref
pharmcda-
|
2017‑01‑02 | ||||||||||
HL7 V2/V3 Datatype Level Template | ||||||||||||
html | ![]() |
2018‑04‑04 15:41:36 | STU1 | |||||||||
Reusable address template | ||||||||||||
html | ![]() |
2018‑04‑04 15:41:43 | ||||||||||
Reusable address template, for use in US Realm CDA Header. | ||||||||||||
html | ![]() |
2018‑04‑04 15:42:34 | ||||||||||
Reusable address template, for use in US Realm CDA Header. |
Templates | 127 |
Transaction | Representing template | Link | as of |
---|---|---|---|
IPS Created | hl7ips-document-template-1 | International Patient Summary | 2020‑05‑08 12:30:59 |
Label | Template id | Template name | Link | as of | |
---|---|---|---|---|---|
6.3.3.4.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.1.5.3.2 | IHE Coded Vital Signs Section | 1.3.6.1.4.1.19376.1.5.3.1.1.5.3.2 | 2015‑10‑05 15:57:07 |
6.3.4.21 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.6 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.7 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.9 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.22 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | IHE Vital Signs Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | 2016‑09‑29 09:22:49 |
6.3.4.22.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | IHE Vital Signs Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | 2016‑09‑29 09:22:49 |
6.3.4.22.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | IHE Vital Signs Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | 2016‑09‑29 09:22:49 |
6.3.4.22.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | IHE Vital Signs Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | 2016‑09‑29 09:22:49 |
IPSSubordSBADM | ![]() |
hl7ips-entry-template-33 | IPS Subordinate SubstanceAdministration | 2.16.840.1.113883.10.22.4.33 | 2017‑06‑15 |
Data sets, codes, OIDs and Rules: this information is used for rendering and validation purposes.